BeOne Medicines Ltd. (ONC) compared with its closest peers (REGN, OGN, ELAN, BMY, ABBV). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Regeneron Pharmaceuticals, Bristol-Myers Squibb and AbbVie: named a competitor in the 10-K.
| Company | Market Cap | P/E |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | $82.84B | 19.1 |
| Organon & Co. (OGN) | $3.58B | 17.1 |
| Elanco Animal Health Incorporated (ELAN) | $11.57B | — |
| Bristol-Myers Squibb Company (BMY) | $129.94B | 14.0 |
| AbbVie Inc. (ABBV) | $454.22B | 72.0 |
| Viatris Inc. (VTRS) | $19.23B | 239.5 |
| Gilead Sciences, Inc. (GILD) | $178.22B | 18.1 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $5.43B | 34.5 |
| Zoetis Inc. (ZTS) | $30.60B | 11.7 |
| ANI Pharmaceuticals, Inc. (ANIP) | $1.54B | 14.2 |
| Sector P/E (Healthcare) | 19.4 |
| Industry P/E (Pharmaceutical Products) | 15.1 |
ONC overview · ONC earnings · ONC financials · ONC KPIs · ONC documents · ONC ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.